Bimekizumab Infection Rates in Patients With Moderate to Severe Plaque Psoriasis: Analysis of Pooled Data from 2 Years of Treatment in Phase 3 and 3b Clinical Trials. J of Skin 2022, 6 (6), s72. https://doi.org/10.25251/skin.6.supp.72.